Search

everythinglearnresearchcommunity

for

Search:↓

Early hair loss in men could be a sign of non-cancerous prostate enlargement, and treating hair loss early might help prevent prostate issues later.

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

Removing both ovaries may better treat increased male hormone levels and related symptoms in postmenopausal women when hormone therapy doesn't work.

Estrogen alone can lower testosterone in some transfeminine people.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Two patients with psoriasis grew extra hair after using certain psoriasis medications.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

A new gene, JMJD1C, may affect testosterone levels in men.

Use "female pattern hair loss" term, assess androgen excess, treat with minoxidil and other medications if needed.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Medications for enlarged prostate can cause sexual side effects like reduced libido, erectile dysfunction, and ejaculatory problems.

Monascus helps prevent baldness, prostate issues, and may be a natural alternative to medications.

Antiandrogens and androgen inhibitors like spironolactone, finasteride, and dutasteride can treat hair loss and skin conditions, but they have risks and side effects, including potential harm to pregnant women and risks of cancer and heart issues. Herbal remedies also have antiandrogenic effects but lack safety validation.

The research found that androgens help control blood flow in the rat prostate through a specific binding site.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Androgens may worsen COVID-19 and hair loss could indicate the disease's severity.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

A new compound, 3a, effectively fights prostate cancer better than finasteride.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Stauntonia hexaphylla extract can help treat hair loss by blocking certain hormones.